Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Shares Outstanding (Diluted Average) (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Shares Outstanding (Diluted Average) for 6 consecutive years, with $222.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) rose 14.93% year-over-year to $222.2 million, compared with a TTM value of $222.2 million through Sep 2025, up 14.93%, and an annual FY2024 reading of $192.9 million, up 1.55% over the prior year.
  • Shares Outstanding (Diluted Average) was $222.2 million for Q3 2025 at Aveanna Healthcare Holdings, up from $206.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $222.2 million in Q3 2025 and bottomed at $170625.0 in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $179.2 million, with a median of $189.1 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Diluted Average) soared 108649.01% in 2022, then rose 1.55% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $170.7 million in 2021, then rose by 8.72% to $185.6 million in 2022, then grew by 2.37% to $190.0 million in 2023, then increased by 1.55% to $192.9 million in 2024, then increased by 15.21% to $222.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for AVAH at $222.2 million in Q3 2025, $206.8 million in Q2 2025, and $206.2 million in Q1 2025.